UHS(US:UHS)2025-10-28 14:02Financial Data and Key Metrics Changes - The company reported adjusted net income attributable to UHS of $5.69 per share, a 53% increase from Q3 2024 [5][12] - Revenue growth for Q3 2025 was 13.4% year over year [5] - The midpoint of 2025 adjusted EPS guidance was increased by 6% to $21.80 per diluted share from $20.50 [7] Business Line Data and Key Metrics Changes - In the acute care segment, same facility adjusted admissions increased by 2.0% year over year, with net revenues increasing by 12.8% [13][14] - Behavioral health segment same-facility net revenues increased by 9.3% on a reported basis, driven by a 7.9% increase in revenue per adjusted patient day [15][16] Market Data and Key Metrics Changes - The company recognized approximately $90 million of net benefit from the District of Columbia Supplemental Medicaid Program during Q3 2025, with $73 million recognized in acute care results [12][13] - The percentage of total adjusted admissions from exchange patients was in the 6 to 6.5% range, with an increase noted [24] Company Strategy and Development Direction - The company is focusing on expanding its outpatient services, operating 45 outpatient access points and planning to open 10 step-in programs this year [9][10] - The next de novo acute care hospital opening is scheduled for spring 2026 in Palm Beach Gardens, Florida, with significant community interest [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term outlook for Cedar Hill Regional Medical Center, expecting it to break even in Q4 2025 and improve in 2026 [7][40] - The company anticipates further volume improvements in the behavioral health segment, targeting 2% to 3% growth in adjusted patient days [16][61] Other Important Information - The company spent $734 million on capital expenditures in the first nine months of 2025, with a significant portion related to new hospital projects [17] - The board authorized a new $1.5 billion increase to the stock repurchase program, bringing the total authorization to $1.759 billion [17] Q&A Session Summary Question: Update on pending Medicaid approvals in Florida and Nevada - Management indicated that Florida's pending plan could result in about a $47 million annual benefit, while Nevada's could add approximately $30 million, pending CMS approval [23] Question: 2025 guidance breakdown - The guidance increase was attributed to $140 million of increased DPP, with $90 million recorded in Q3 and $25 million expected in Q4, offset by malpractice and legal settlement costs [29][30] Question: Behavioral health business and state budget impacts - Management noted that while managed care players are aggressive in utilization management, they have not seen significant changes in payer behavior, and state budget cuts have not materially affected their operations [33][34] Question: Performance of West Henderson Hospital - West Henderson Hospital has been performing well, contributing positively to EBITDA since opening, though it has slightly impacted same-store adjusted admissions [38] Question: Trends in outpatient surgical initiatives - Outpatient surgical trends improved slightly over the prior year, with case mix up slightly, indicating a return to more normal levels [44][46] Question: Future margin trends - Management expressed confidence in achieving sustainable margins, with expectations for continued growth in both acute and behavioral segments [100]